The Classification and Diagnosis of Headache Disorders

Jes Olesen is Professor of Neurology, University of Copenhagen, Chairman of Danish Headache Center, Glostrup Hospital, University of Copenhagen, Denmark

F. Alarcón, Latin American Migraine Study Group; Andrea Alberti, Neuroscience Department, University of Perugia, Italy; N. Aranaga, Latin American Migraine Study Group; Messoud Ashina, Danish Headache Center and Department of Neurology, Glostrup Hospital, University of Copenhagen, Denmark; Sait Ashina, Danish Headache Center and Department of Neurology, Glostrup Hospital, University of Copenhagen, Denmark; S. Aulet, Latin American Migraine Study Group; A. Autret, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); G. Baudesson, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); E. Beghi, Mario Negri Institute and Neurological Clinic, University of Milano-Bicocca, Milan, Italy; Lars Bendtsen, The Danish Headache Center, Department of Neurology, University of Copenhagen, Glostrup Hospital, Denmark; Marcelo E. Bigal, Department of Neurology, Epidemiology and Population Health, Albert Einstein College of Medicine, and Montefiore Headache Clinic, New York, The New England Center for Headache, Stamford, USA; Marie-Germaine Bousser, Service de Neurologie, Hôpital Lariboisière, Paris, France; Rami Burstein, Department of Anesthesia and Critical Care, Harvard Institutes of Medicine, Boston, USA; Giuseppe Capocchi, Neurologic Clinic, Department of Neuroscience, University of Perugia, Italy; Alberto P. Cecchini, University Centre for Adaptive Disorders and Headache, IRCCS "C Mondino" Foundation, Pavia, Italy; E. Chapman, Latin American Migraine Study Group; M. H. Chautard, Astra Zeneca, France; L. Conterno, Latin American Migraine Study Group; Donatella Corigliano, Department of Neurology and Otholaringology, University of Rome La Sapienza, Italy; J. Couch, University of Oklahoma Health Sciences Center, Oklahoma City, USA; C. Creach, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); D. Dodick, Mayo Clinic, Scottsdale, USA; A. Donnet, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); V. Dousset, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); Malene K. Eriksen, Danish Headache Center, University of Copenhagen, Department of Neurology, Glostrup University Hospital, Denmark; E. Estévez, Latin American Migraine Study Group; F. Fabre, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); Michel D. Ferrari, Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands; Daniela Fortini, IRCCS S. Lucia, Rome, Italy; F. Garcia-Pedroza, Latin American Migraine Study Group; J. Garrido, Latin American Migraine Study Group; G. Géraud, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); U. Gessner, Bayer Vital GmbH, Consumer-Care, Cologne, Germany; Natascia Ghiotto, University Centre for Adaptive Disorders and Headache, IRCCS "C Mondino" Foundation, Pavia, Itsly; Patrizia Giacomini, Department of Neurology and Otholaringology, University of Rome La Sapienza, Italy; Rosario Gil, Department of Neurology, Hospital Clinico Universitario, University of Valencia, Spain; G. Giraud, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); M. Girot, Department of Neurology, Lille University Hospital, France; Peter J. Goadsby, Headache Group, Institute of Neurology, London, UK; Sances Grazia, University Centre for Adaptive Disorders and Headache, IRCCS "C Mondino" Foundation, Pavia, Italy; E. Guaschino, University Centre for Adaptive Disorders and Headache, IRCCS "C Mondino" Foundation, Pavia, Italy; E. Guégan-Massardier, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); N. Guy, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); Hartmut Göbel, Kiel Pain Clinic, Kiel, Germany; Axel Heinze, Kiel Pain Clinic, Kiel, Germany; Katja Heinze-Kuhn, Kiel Pain Clinic, Kiel, Germany; H. Hénon, Department of Neurology, Lille University Hospital, France; J. Hettiarachchi, Pfizer Inc, New York, USA; Moshe Jakubowski, Department of Anesthesia and Critical Care, Harvard Medical School, Boston, USA; Rigmor Jensen, The Danish Headache Center, Department of Neurology, University of Copenhagen, Glostrup Hospital, Denmark; K. Kolodnor, IMR, AdvancePCA, Hunt Valley, USA; Christian Kubisch, Institute of Human Genetics, University of Bonn, Germany; R. Kunickas, Traumatology Emergency Ward, Red Cross Hospital, Kaunas, Lithuania; Miguel J. A. Láinez, Department of Neurology, Hospital Clinico Universitaria, Valencia, Spain; James W. Lance, Institute of Neurological Sciences, Prince of Wales Hospital, Woollahra, Australia; M. Lanteri-Minet, Department of Evaluation and Treatment of Pain, Hopital Pasteur, Nice, France; J. Leston, Latin American Migraine Study Group; D. Leys, Department of Neurology, Lille University Hospital, France; Richard B. Lipton, Departments of Neurology, Epidemiology and Social Medicine, Albert Einstein College of Medicine, New York, USA; C. Lucas, Department of Neurology, Lille University Hospital, France; M. Macias-Islas, Latin American Migraine Study Group; M. A. Mackowiak, Department of Neurology, Lille University Hospital, France; G. C. Manzoni, Headache Center, Section of Neurology, Department of Neuroscience, University of Parma, Italy; Pasquale Marchione, Department of Neurology and Otholaringology, University of Rome La Sapienza, Italy; H. Massiou, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); Giovanni Mazzotta, Neuroscience Department, University of Perugia, Italy; G. Mick, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); D. Mickeviciene, Department of Neurology, Red Cross Hospital, Kaunas Lithuania and Department of Neurology, Medical University Clinic, Kaunas, Lithuania; P. Monzillo, Latin American Migraine Study Group; L. E. Morillo, Javeriana University, Bogotá, Colombia; Giuseppe Nappi, University Centre for Adaptive Disorders and Headache, IRCCS "C Mondino" Foundation, Pavia and Department of Neurology and Otolaryngology, University La Sapienza, Rome, Italy; M. Navez, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); L. Núnez, Latin American Migraine Study Group; D. Obelieniene, Department of Neurology, Medical University Clinic, Kaunas, Lithuania; Jes Olesen, Department of Neurology, Glostrup Hospital, University of Copenhagen, Denmark; Ana M. Pascual, Department of Neurology, Hospital Clinico Universitario, University of Valencia, Spain; Mauro Pedini, Computer Science Educational Laboratory, Faculty of Medicine, Neurologic Clinic, University of Perugia, Italy; A. Perez, Latin American Migraine Study Group; M. Petersen-Braun, Bayer Vital GmbH, Consumer-Care, Cologne, Germany; N. Plascencia, Latin American Migraine Study Group; A. Pradalier, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); F. Radat, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); C. Rodriguez, Latin American Migraine Study Group; Fumihiko Sakai, Kitasato University Hospital, Sagamihara Kanagawa, Japan; Antonio Salvador, Department of Neurology, Hospital Clinico Universitario, University of Valencia, Spain; Domenico Samá, Department of Neurology and Otholaringology, University of Rome La Sapienza, Italy; T. Sand, Norwegian National Headache Center, Trondheim University Hospital, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Giorgio Sandrini, University Centre for Adaptive Disorders and Headache, IRCCS "C Mondino" Foundation, Pavia, Italy; L. C. Sanin, Latin American Migraine Study Group; Paola Sarchielli, Neurologic Clinic, Neuroscience Department, University of Perugia, Italy; H. Schrader, Norwegian National Headache Center, Trondheim University Hospital, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Stephen Silberstein, Director, Jefferson Headache Center and Professor of Neurology, Thomas Jefferson University Hospital, Philadelphia, USA; F. Silva, Latin American Migraine Study Group; N. Simonovis, Latin American Migraine Study Group; L. J. Stovner, Norwegian National Headache Center, Trondheim University Hospital, Faculty of Medicine, Norwegian University of Science and Technology, Norway; D. Surkiene, Department of Neurology, Medical University Clinic, Kaunas, Lithuania; Y. Takeuchi, Latin American Migraine Study Group; Cristina Tassorelli, University Centre for Adaptive Disorders and Headache, IRCCS "C Mondino" Foundation, Pavia, Italy; Lise Lykke, Thomsen,Danish Headache Center, University of Copenhagen, Department of Neurology, Glostrup, University Hospital, Denmark; Unda Todt, Institute of Human Genetics, University of Bonn, Germany; P. Torelli, Headache Center, Section of Neurology, Department of Neuroscience, University of Parma, Italy; D. Valade, Société Francaise d'Etudes Des Migraines et Céphalées (SFEMC); Claudio Vento, Department of Neurology and Otholaringology, University of Rome La Sapienza, Italy; M. Viallet, Department of Neurology, Lille University Hospital, France; U. Weingärtner, Bayer Vital GmbH, Consumer-Care, Cologne, Germany; Natalie J. Wiendels, Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands; A. Waage, Department of Medicine, Section for Hematology, Trondheim University Hospital, Norwegian University of Science and Technology, Norway; A. H. Aamodt, Norwegian National Headache Centre, Trondheim University Hospital, Norwegian University of Science and Technology, Norway.